AlphaYouMW
Insider selling
Matthew Wein sold $725 of Metagenomi Therapeutics, Inc. (MGX) stock
Matthew Wein sold 558 shares of MGX stock worth $725, per an SEC Form 4 filed Jun 10, 2026.
It was an open-market sale.
The trade happened on Jun 5, 2026, 5 days before it was made public.
MGX has moved -12.5% since the trade date, from $1.28 to $1.12 (Sep 21, 2026 close).
- Traded
- Jun 5, 2026
- Disclosed
- Jun 10, 2026
- Filing delay
- 5 days
- Price since
- -12.5%
- Source
- SEC Form 4
More MGX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.